CV Sciences Eagerly Anticipating FDA Rulemaking On CBD In Dietary Supplements

Duffy MacKay, senior VP of scientific and regulatory affairs at CV Sciences, offers his predictions regarding the FDA’s likely course in regulating CBD’s use in dietary supplements – action that is sorely needed as the market continues to crowd with CBD products “with who-knows-what in them.”

CBD Molecule

CV Sciences, Inc. is confident that the US Food and Drug Administration will establish a regulatory framework for cannabidiol’s lawful use in dietary supplements, which it believes will be a crucial accelerator for its already market-leading PlusCBD brand.

In recent years, the San Diego-based company has been working to grow US distribution for the PlusCBD line, including moves...

HBW Podcast

Explore how consumer health is evolving. On the go.

David Ridley hosts in-depth conversations with industry leaders.

More from United States

More from North America